143 related articles for article (PubMed ID: 34621476)
21. The role of adjuvant chemotherapy in rectal cancer patients with ypT0-2N0 after neoadjuvant chemoradiotherapy.
Yang J; Deng Q; Chen Z; Chen Y; Fu Z
Front Oncol; 2024; 14():1338098. PubMed ID: 38406812
[TBL] [Abstract][Full Text] [Related]
22. Effect of Adjuvant Chemotherapy on Stage II Rectal Cancer Outcomes After Preoperative Short-Course Radiotherapy.
Loree JM; Kennecke HF; Renouf DJ; Lim HJ; Vickers MM; Speers CH; Cheung WY
Clin Colorectal Cancer; 2016 Dec; 15(4):352-359.e1. PubMed ID: 27265355
[TBL] [Abstract][Full Text] [Related]
23. Is the pathological regression level of metastatic lymph nodes associated with oncologic outcomes following preoperative chemoradiotherapy in rectal cancer?
Choi JP; Kim SJ; Park IJ; Hong SM; Lee JL; Yoon YS; Kim CW; Lim SB; Lee JB; Yu CS; Kim JC
Oncotarget; 2017 Feb; 8(6):10375-10384. PubMed ID: 28060748
[TBL] [Abstract][Full Text] [Related]
24. Overuse and Limited Benefit of Chemotherapy for Stage II Colon Cancer in Young Patients.
Birkett RT; Chamely E; Concors SJ; Bleier JI; Aarons CB; Shanmugan S; Saur NM; Paulson EC
Clin Colorectal Cancer; 2019 Dec; 18(4):292-300. PubMed ID: 31447135
[TBL] [Abstract][Full Text] [Related]
25. Efficacy of preoperative chemoradiotherapy in patients with cT2N0 distal rectal cancer.
Park MY; Yu CS; Kim TW; Kim JH; Park JH; Lee JL; Yoon YS; Park IJ; Lim SB; Kim JC
Ann Coloproctol; 2023 Jun; 39(3):250-259. PubMed ID: 35368177
[TBL] [Abstract][Full Text] [Related]
26. Postoperative chemotherapy is associated with prognosis of stage IV colorectal cancer treated with preoperative chemotherapy/chemoradiotherapy and curative resection.
Nozawa H; Sonoda H; Ishii H; Emoto S; Murono K; Kaneko M; Sasaki K; Nishikawa T; Shuno Y; Tanaka T; Kawai K; Hata K; Ishihara S
Int J Colorectal Dis; 2020 Jan; 35(1):177-180. PubMed ID: 31807855
[TBL] [Abstract][Full Text] [Related]
27. Recurrence rates and prognostic factors in ypN0 rectal cancer after neoadjuvant chemoradiation and total mesorectal excision.
Govindarajan A; Reidy D; Weiser MR; Paty PB; Temple LK; Guillem JG; Saltz LB; Wong WD; Nash GM
Ann Surg Oncol; 2011 Dec; 18(13):3666-72. PubMed ID: 21590450
[TBL] [Abstract][Full Text] [Related]
28. [Value of postoperative adjuvant chemotherapy in locally advanced rectal cancer patients with ypT1-4N0 after neo-adjuvant chemoradiotherapy].
You KY; Peng HH; Gao YH; Chen L; Zhou GQ; Chang H; Du XJ; Xiao L; Zeng ZF; Wen BX; Liu MZ
Zhonghua Zhong Liu Za Zhi; 2013 Sep; 35(9):708-13. PubMed ID: 24332061
[TBL] [Abstract][Full Text] [Related]
29. Significance of perineural and lymphovascular invasion in locally advanced rectal cancer treated by preoperative chemoradiotherapy and radical surgery: Can perineural invasion be an indication of adjuvant chemotherapy?
Song JH; Yu M; Kang KM; Lee JH; Kim SH; Nam TK; Jeong JU; Jang HS; Lee JW; Jung JH
Radiother Oncol; 2019 Apr; 133():125-131. PubMed ID: 30935568
[TBL] [Abstract][Full Text] [Related]
30. Pathologic complete response of primary tumor following preoperative chemoradiotherapy for locally advanced rectal cancer: long-term outcomes and prognostic significance of pathologic nodal status (KROG 09-01).
Yeo SG; Kim DY; Kim TH; Chang HJ; Oh JH; Park W; Choi DH; Nam H; Kim JS; Cho MJ; Kim JH; Park JH; Kang MK; Koom WS; Kim JS; Nam TK; Chie EK; Kim JS; Lee KJ
Ann Surg; 2010 Dec; 252(6):998-1004. PubMed ID: 21107110
[TBL] [Abstract][Full Text] [Related]
31. The Need for Effective Adjuvant Therapy in Uterine Leiomyosarcoma: A Single-centre Experience.
Eraslan E; Yildiz F; Ilhan A; Dogan M
J Coll Physicians Surg Pak; 2021 Aug; 31(8):926-931. PubMed ID: 34320709
[TBL] [Abstract][Full Text] [Related]
32. Oncologic outcome after preoperative chemoradiotherapy in patients with pathologic T0 (ypT0) rectal cancer.
Jang TY; Yu CS; Yoon YS; Lim SB; Hong SM; Kim TW; Kim JH; Kim JC
Dis Colon Rectum; 2012 Oct; 55(10):1024-31. PubMed ID: 22965400
[TBL] [Abstract][Full Text] [Related]
33. Rectal cancer patients after neoadjuvant radiotherapy (30Gy/10f) with negative lymph node may not benefit from postoperative adjuvant chemotherapy: a retrospective study.
Chen P; Yao Y; Gu J
Int J Colorectal Dis; 2015 Dec; 30(12):1695-704. PubMed ID: 26278877
[TBL] [Abstract][Full Text] [Related]
34. Role of adjuvant therapy after R0 resection for patients with distal cholangiocarcinoma.
Kim YS; Hwang IG; Park SE; Go SI; Kang JH; Park I; Oh SY; Ji JH; Song HN; Park SH; Kim ST; Park JO
Cancer Chemother Pharmacol; 2016 May; 77(5):979-85. PubMed ID: 27017615
[TBL] [Abstract][Full Text] [Related]
35. Adjuvant chemotherapy with or without pelvic radiotherapy after simultaneous surgical resection of rectal cancer with liver metastases: analysis of prognosis and patterns of recurrence.
An HJ; Yu CS; Yun SC; Kang BW; Hong YS; Lee JL; Ryu MH; Chang HM; Park JH; Kim JH; Kang YK; Kim JC; Kim TW
Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):73-80. PubMed ID: 22300562
[TBL] [Abstract][Full Text] [Related]
36. Adjuvant chemotherapy and survival outcomes in rectal cancer patients with good response (ypT0-2N0) after neoadjuvant chemoradiotherapy and surgery: A retrospective nationwide analysis.
Kuo YH; Lin YT; Ho CH; Chou CL; Cheng LC; Tsai CJ; Hong WJ; Chen YC; Yang CC
Front Oncol; 2022; 12():1087778. PubMed ID: 36591443
[TBL] [Abstract][Full Text] [Related]
37. Adjuvant chemotherapy for patients with ypT0-2N0-category after neoadjuvant chemoradiotherapy for rectal cancer.
Wan JF; Yang LF; Zhu J; Li GC; Zhang Z
Mol Clin Oncol; 2017 Nov; 7(5):864-868. PubMed ID: 29181181
[TBL] [Abstract][Full Text] [Related]
38. Adjuvant Chemotherapy Does Not Improve Recurrence-Free Survival in Patients With Stage 2 or Stage 3 Rectal Cancer After Neoadjuvant Chemoradiotherapy and Total Mesorectal Excision.
Voss RK; Lin JC; Roper MT; Al-Temimi MH; Ruan JH; Tseng WH; Tam M; Sherman MJ; Klaristenfeld DD; Tomassi MJ
Dis Colon Rectum; 2020 Apr; 63(4):427-440. PubMed ID: 31996583
[TBL] [Abstract][Full Text] [Related]
39. Oncologic effects of adjuvant chemotherapy in patients with ypT0-2N0 rectal cancer after neoadjuvant chemoradiotherapy and curative surgery: a meta-analysis.
Ha GW; Lee MR
Ann Surg Treat Res; 2020 Aug; 99(2):97-109. PubMed ID: 32802815
[TBL] [Abstract][Full Text] [Related]
40. Monthly tegafur-uracil maintenance for increasing relapse-free survival in ypStage III rectal cancer patients after preoperative radiotherapy, radical resection, and 12 postoperative chemotherapy cycles: a retrospective study.
Kuo YH; Lai CH; Huang CY; Chen CJ; Huang YC; Huang WS; Chin CC
BMC Cancer; 2019 Aug; 19(1):815. PubMed ID: 31419963
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
